Literature DB >> 6812106

Methylphenidate oral dose plasma concentrations and behavioral response in children.

B G Winsberg, S S Kupietz, J Sverg, B L Hungund, N L Young.   

Abstract

The relationship between methylphenidate (MP) oral dose and plasma concentration to social and cognitive behaviors was studied in 25 boys diagnosed as having "attention deficit disorder with hyperactivity". Children were administered successive 1-week treatment conditions under the following schedule of fixed oral doses given twice daily: placebo; 0.25 mg/kg; 0.50 mg/kg; 1.0 mg/kg; placebo. Teacher and parent ratings showed increased improvement in social behavior as a function of MP dose. No drug effects were obtained on cognitive performance. MP plasma concentrations were significantly associated with oral dose and with measures of social behavior. No relationship was found with cognitive behavior. Side effects at the largest dose were severe enough to require discontinuation of treatment for five children, but were relatively mild for the remaining children.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6812106     DOI: 10.1007/bf00449120

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  12 in total

1.  Pharmacologic management of children with hyperactive/aggressive/inattentive behavior disorders. Suggestions for the pediatrician.

Authors:  B G Winsberg; L E Yepes; I Bialer
Journal:  Clin Pediatr (Phila)       Date:  1976-05       Impact factor: 1.168

2.  The effects of long-term stimulant medication on growth and body composition of hyperactive children.

Authors:  B McNutt; J E Ballard; R Boileau
Journal:  Psychopharmacol Bull       Date:  1976-04

3.  Methylphenidate in children--effect of dosage.

Authors:  J S Werry; R L Sprague
Journal:  Aust N Z J Psychiatry       Date:  1974-03       Impact factor: 5.744

4.  A teacher rating scale for use in drug studies with children.

Authors:  C K Conners
Journal:  Am J Psychiatry       Date:  1969-12       Impact factor: 18.112

5.  Methylphenidate and haloperidol in children. Effects on attention, memory, and activity.

Authors:  J S Werry; M G Aman
Journal:  Arch Gen Psychiatry       Date:  1975-06

6.  Paying attention to attention deficit disorder.

Authors:  J E Schowalter
Journal:  Pediatrics       Date:  1979-10       Impact factor: 7.124

7.  Pharmacokinetics of methylphenidate in hyperkinetic children.

Authors:  B L Hungund; J M Perel; M J Hurwic; J Sverd; B G Winsberg
Journal:  Br J Clin Pharmacol       Date:  1979-12       Impact factor: 4.335

8.  Methylphenidate in hyperkinetic children: differences in dose effects on impulsive behavior.

Authors:  R T Brown; E K Sleator
Journal:  Pediatrics       Date:  1979-10       Impact factor: 7.124

9.  A sensitive gas chromatographic method for the determination of methylphenidate (Ritalin) and its major metabolite alpha-phenyl-2-piperidine acetic acid (ritalinic acid) in human plasma using nitrogen-phosphorous detector.

Authors:  B L Hungund; M Hanna; B G Winsberg
Journal:  Commun Psychopharmacol       Date:  1978

10.  Methylphenidate in hyperkinetic children: differences in dose effects on learning and social behavior.

Authors:  R L Sprague; E K Sleator
Journal:  Science       Date:  1977-12-23       Impact factor: 47.728

View more
  4 in total

1.  Enantioselective pharmacokinetics of dl-threo-methylphenidate in humans.

Authors:  N R Srinivas; J W Hubbard; E D Korchinski; K K Midha
Journal:  Pharm Res       Date:  1993-01       Impact factor: 4.200

Review 2.  Risks and benefits of drugs used in the management of the hyperactive child.

Authors:  A M Fox; M J Rieder
Journal:  Drug Saf       Date:  1993-07       Impact factor: 5.606

3.  Effects of methylphenidate on working memory in pigeons.

Authors:  Fiona K Wright; K Geoffrey White
Journal:  Cogn Affect Behav Neurosci       Date:  2003-12       Impact factor: 3.282

Review 4.  Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.

Authors:  Ole Jakob Storebø; Nadia Pedersen; Erica Ramstad; Maja Lærke Kielsholm; Signe Sofie Nielsen; Helle B Krogh; Carlos R Moreira-Maia; Frederik L Magnusson; Mathilde Holmskov; Trine Gerner; Maria Skoog; Susanne Rosendal; Camilla Groth; Donna Gillies; Kirsten Buch Rasmussen; Dorothy Gauci; Morris Zwi; Richard Kirubakaran; Sasja J Håkonsen; Lise Aagaard; Erik Simonsen; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2018-05-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.